Pacira reported $378.1M in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Astellas Pharma JPY 558.08B 6.82B Jun/2025
Bristol-Myers Squibb USD 44.47B 1.69B Jun/2025
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
J&J USD 38.36B 7.7B Mar/2025
Ligand Pharmaceuticals USD 0 0 Mar/2025
Novo Nordisk 87.3B 9.01B Jun/2025
Pacira USD 378.1M 3.2M Jun/2025
Perrigo USD 3.62B 24.2M Jun/2025
Pfizer USD 57.5B 137M Jun/2025
Supernus Pharmaceuticals USD 0 0 Dec/2024
Teva Pharmaceutical Industries USD 16.76B 533M Jun/2025
Xeris Pharmaceuticals USD 218.63M 1.62M Jun/2025
Zoetis USD 5.23B 4M Jun/2025